Cystitis, a common side effect observed in patients that receive CYP [59,60], ensues as acrolein accumulates in the urinary bladder causing pelvic allodynia (i.e., pain due to a stimulus that does not normally provoke pain), frequent voiding events of low volume and inflammation. This evidence concerns the gene PPIG and cystitis.